Skip Nav Destination
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial
Superior survival associated with transplantation of matched unrelated versus one-antigen–mismatched unrelated or highly human leukocyte antigen– disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients
Therapy-related myelodysplastic syndrome–acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation
Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy
Issue Archive
February 1 2002
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial
Clinical Trials & Observations
Philippe Moreau,Thierry Facon,Michel Attal,Cyrille Hulin,Mauricette Michallet,Frédéric Maloisel,Jean-Jacques Sotto,François Guilhot,Gérald Marit,Chantal Doyen,Jérôme Jaubert,Jean-Gabriel Fuzibet,Sylvie François,Lotfi Benboubker,Matthieu Monconduit,Laurent Voillat,Margaret Macro,Christian Berthou,Véronique Dorvaux,Bernard Pignon,Bernard Rio,Thomas Matthes,Philippe Casassus,Denis Caillot,Norbert Najman,Bernard Grosbois,Régis Bataille,Jean-Luc Harousseau,for the Intergroupe Francophone du Myélome
PERSPECTIVE
REVIEW ARTICLES
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Superior survival associated with transplantation of matched unrelated versus one-antigen–mismatched unrelated or highly human leukocyte antigen– disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts
Clinical Trials & Observations
William R. Drobyski,John Klein,Neal Flomenberg,Daniel Pietryga,David H. Vesole,David A. Margolis,Carolyn A. Keever-Taylor
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients
Clinical Trials & Observations
Motoko Yamaguchi,Masao Seto,Masataka Okamoto,Ryo Ichinohasama,Naoya Nakamura,Tadashi Yoshino,Junji Suzumiya,Takuhei Murase,Ikuo Miura,Takashi Akasaka,Jun-ichi Tamaru,Ritsuro Suzuki,Yoshitoyo Kagami,Masami Hirano,Yasuo Morishima,Ryuzo Ueda,Hiroshi Shiku,Shigeo Nakamura
Therapy-related myelodysplastic syndrome–acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem
Clinical Trials & Observations
Roberto Latagliata,Maria Concetta Petti,Susanna Fenu,Marco Mancini,Maria Antonietta Aloe Spiriti,Massimo Breccia,Gregorio A. Brunetti,Giuseppe Avvisati,Francesco Lo Coco,Franco Mandelli
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Clinical Trials & Observations
Beverly J. Lange,Bruce C. Bostrom,Joel M. Cherlow,Martha G. Sensel,Mei K. L. La,Wayne Rackoff,Nyla A. Heerema,Robert S. Wimmer,Michael E. Trigg,Harland N. Sather
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
Clinical Trials & Observations
Francesco Onida,Hagop M. Kantarjian,Terry L. Smith,Greg Ball,Michael J. Keating,Elihu H. Estey,Armand B. Glassman,Maher Albitar,Monica I. Kwari,Miloslav Beran
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma
Clinical Trials & Observations
Alessandro Rambaldi,Manuela Lazzari,Cristina Manzoni,Emanuela Carlotti,Luca Arcaini,Michele Baccarani,Tiziano Barbui,Carlo Bernasconi,Giuseppe Dastoli,Giovanna Fuga,Enrica Gamba,Livio Gargantini,Valter Gattei,Francesco Lauria,Mario Lazzarino,Franco Mandelli,Enrica Morra,Alessandro Pulsoni,Michela Ribersani,Pier Luigi Rossi-Ferrini,Maurizio Rupolo,Sante Tura,Vittorina Zagonel,Francesco Zaja,PierLuigi Zinzani,Gigliola Reato,Robin Foa
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study
Clinical Trials & Observations
Luciana Annino,Maria Luce Vegna,Andrea Camera,Giorgina Specchia,Giuseppe Visani,Giuseppe Fioritoni,Felicetto Ferrara,Antonio Peta,Stefania Ciolli,Wilma Deplano,Francesco Fabbiano,Simona Sica,Francesco Di Raimondo,Nicola Cascavilla,Antonio Tabilio,Pietro Leoni,Rosangela Invernizzi,Michele Baccarani,Bruno Rotoli,Sergio Amadori,Franco Mandelli,for the GIMEMA Group
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1
Gunther G. Pendl,Caroline Robert,Meike Steinert,Renate Thanos,Ruth Eytner,Eric Borges,Martin K. Wild,John B. Lowe,Robert C. Fuhlbrigge,Thomas S. Kupper,Dietmar Vestweber,Stephan Grabbe
Adenosine deaminase deficiency with mosaicism for a “second-site suppressor” of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy
Francisco X. Arredondo-Vega,Ines Santisteban,Eva Richard,Pawan Bali,Majed Koleilat,Michael Loubser,Abdulaziz Al-Ghonaium,Mariam Al-Helali,Michael S. Hershfield
NEOPLASIA
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease
Terry J. Hamblin,Jenny A. Orchard,Rachel E. Ibbotson,Zadie Davis,Peter W. Thomas,Freda K. Stevenson,David G. Oscier
PHAGOCYTES
RED CELLS
TRANSPLANTATION
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen
Ronjon Chakraverty,Karl Peggs,Rajesh Chopra,Donald W. Milligan,Panagiotis D. Kottaridis,Stephanie Verfuerth,Johanne Geary,Dharsha Thuraisundaram,Kate Branson,Suparno Chakrabarti,Premini Mahendra,Charles Craddock,Anne Parker,Ann Hunter,Geoff Hale,Herman Waldmann,Catherine D. Williams,Kwee Yong,David C. Linch,Anthony H. Goldstone,Stephen Mackinnon
BRIEF REPORTS
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation
Clinical Trials & Observations
Brief Report
Amelia A. Langston,Istvan Redei,Angela M. Caliendo,Jyoti Somani,Don Hutcherson,Sagar Lonial,Silvana Bucur,Judy Cherry,Andrew Allen,Edmund K. Waller
Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy
Clinical Trials & Observations
Brief Report
Elena Santagostino,Maria Grazia Rumi,Monica Rivi,Massimo Colombo,Pier Mannuccio Mannucci,for the Hepatitis Study Group of the Association of Italian Hemophilia Centers
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals